ArticleBritish journal of pharmacology2017

Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.

Arun Samidurai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.